Adherence to lifestyle modifications profoundly influences outcomes
64 Similar results of significant reduction in a composite of cardiovascular death or heart failure-associated hospitalization of patients, with or without diabetes, receiving an SGLT2i, were observed in the EMPEROR-Reduced, EMPEROR-Preserved (empagliflozin) and the DAPA-HF (dapagliflozin) studies
22, 2026 at 9:41 AM EDT | Defense Secretary Pete Hegseth announced a new testosterone-deficiency screening program for service members, but endocrinologist and former military doctor Dr
To measure the insulinotropic effects of GLP-1 (7-37) in a physiologically relevant animal model, Habener reached out to his friend Gordon Weir, an endocrinologist based at the Joslin Diabetes Center and Harvard Medical School
For the past 12 weeks, Marquez has taken a host of supplements as part of a firefighter detox program